Therapy for acne vulgaris

New England Journal of Medicine

Volumn 336, Issue 16, 1997, Pages 1156-1162

  Leyden, James J ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ANTI ACNE AGENT; ANTIANDROGEN; ANTIBIOTIC AGENT; AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; ESTROGEN; GLYCOLIC ACID; ISOTRETINOIN; METRONIDAZOLE; MINOCYCLINE; ORAL CONTRACEPTIVE AGENT; RETINOIC ACID; SALICYLIC ACID; SPIRONOLACTONE; TAZAROTENE; TETRACYCLINE;

ACNE VULGARIS; ANTIBIOTIC THERAPY; CONTACT ALLERGY; DISEASE SEVERITY; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; REVIEW; SEBUM SECRETION; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; HUMANS; KERATOLYTIC AGENTS; PROPIONIBACTERIUM ACNES; RETINOIDS;

CORYNEBACTERIUM; PROPIONIBACTERIUM ACNES;

EID: 0030876161     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199704173361607     Document Type: Review

References (54)

1. Kraning KK, Odland GF. Prevalence, morbidity, and cost of dermatological diseases. J Invest Dermatol 1979;73:Suppl:395-401.
2. Koo JY, Smith LL. Psychologic aspects of acne. Pediatr Dermatol 1991; 8:185-8.
3. Strauss JS, Pochi PE, Downing DT. Acne: perspectives. J Invest Dermatol 1974;62:321-5.
4. Harris HH, Downing DT, Stewart ME, Strauss JS. Sustainable rates of sebum secretion in acne patients and matched normal control subjects. J Am Acad Dermatol 1983;8:200-3.
5. Strauss JS, Kligman AM. The pathologic dynamics of acne vulgaris. Arch Dermatol 1960;82:779-90.
6. Knutson DD. Ultrastructural observations in acne vulgaris: the normal sebaceous follicle and acne lesions. J Invest Dermatol 1974;62:288-307.
7. Lavker RM, Leyden JJ. Lamellar inclusions in follicular horny cells: a new aspect of abnormal keratinization. J Ultrastruct Res 1979;69:362-70.
8. Kligman AM, Katz AG. Pathogenesis of acne vulgaris. I. Comedogenic properties of human sebum in external ear canal of the rabbit. Arch Dermatol 1968;98:53-7.
9. Leyden JJ, McGinley KJ, Mills OH Jr, Kligman AM. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 1975; 65:382-4.
10. Marples RR, Leyden JJ, Stewart RN, Mills OH Jr, Kligman AM. The skin microflora in acne vulgaris. J Invest Dermatol 1974;62:37-41.
11. Webster GF, Leyden JJ. Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation 1980;4:261-9.
12. Puhvel SM, Sakamoto M. The chemoattractant properties of comedonal components. J Invest Dermatol 1978;71:324-9.
13. Webster GF, Leyden JJ, Nilsson UR. Complement activation in acne vulgaris: consumption of complement by comedones. Infect Immun 1979; 26:183-6.
14. Webster GF, Leyden JJ, Norman ME, Nilsson UR. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immun 1978;22:523-9.
15. Puhvel SM, Hoffman IK, Sternberg TH. Presence of complement fixing antibodies to Corynebacterium acnes in the sera of patients with acne vulgaris. Arch Dermatol 1966;93:364-6.
16. Vowels BR, Yang S, Leyden JJ. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 1995;63:3158-65.
17. Downing DT, Stewart ME, Wertz PW, Strauss JS. Essential fatty acids and acne. J Am Acad Dermatol 1986;14:221-5.
18. Pye RJ, Meyrick G, Pye MJ, Burton JL. Effect of oral contraceptives on sebum excretion rate. BMJ 1977;2:1581-2.
19. Strauss JS, Pochi PE. Effect of cyclic progestin-estrogen therapy on sebum and acne in women. JAMA 1964;190:815-9.
20. Hammerstein J, Meckies J, Leo-Rossberg I, Moltz L, Zielske F. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism, and virilism. J Steroid Biochem 1975;6:827-36.
21. Hammerstein J, Moltz L, Schwartz U. Antiandrogens in the treatment of acne and hirsutism. J Steroid Biochem 1983;19:591-7.
22. Lehucher-Ceyrac D, Weber-Buisset M-J, Saurat J-H. Réduction de l'excrétion sébacée et amélioration de l'acné chez des patientes traitées par l'association: acétate de cyprotérone - éthinyl oestradiol. Ann Dermatol Venereol 1981;108:861-8.
23. Miller JA, Wojnarowska FT, Dowd PM, et al. Anti-androgen treatment in women with acne: a controlled trial. Br J Dermatol 1986;114:705-16.
24. Goodfellow A, Alaghband-Zadeh J, Carter G, et al. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Br J Dermatol 1984;111:209-14.
25. Burke BM, Cunliffe WJ. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia. Br J Dermatol 1985; 112:124-5.
26. Peck GL, Olsen TG, Yoder FW, et al. Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. N Engl J Med 1979;300: 329-33.
27. Strauss JS, Rapini RP, Shalita AR, et al. Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol 1984; 10:490-6.
28. Jones DH, King K, Miller AJ, Cunliffe WJ. A dose-response study of 13-cis-retinoic acid in acne vulgaris. Br J Dermatol 1983;108:333-43.
29. Layton AM, Stainforth JM, Cunliffe WJ. Ten years' experience of oral isotrctinoin for the treatment of acne vulgaris. J Dermatol Treat 1993;4: Suppl 2:S2-S5.
30. Harms M, Masouye I, Radeff B. The relapses of cystic acne after isotretinoin treatment are age-related: a long-term follow-up study. Dermatologica 1986;172:148-53.
31. Kligman AM, Fulton JE Jr, Plewig G. Topical vitamin A acid in acne vulgaris. Arch Dermatol 1969;99:469-76.
32. Chalker DK, Lesher JL Jr, Smith JG Jr, et al. Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: results of a multicenter, double-blind investigation. J Am Acad Dermatol 1987;17:251-4.
33. Leyden JJ, Marples RR, Mills OH, Kligman AM. Tretinoin and antibiotic therapy in acne vulgaris. South Med J 1974;67:20-5.
34. Kligman AM, Mills OH, McGinley KJ, Leyden JJ. Acne therapy with tretinoin in combination with antibiotics. Acta Dermatol Venereol Suppl (Stockh) 1975;74:111-5.
35. Plewig G, Kligman AM. Acne: morphogenesis and treatment. Berlin, Germany: Springer-Verlag, 1975:274-9.
36. Dalziel K, Barton S, Marks R. The effects of isotretinoin on follicular and sebaceous gland differentiation. Br J Dermatol 1987;117:317-23.
37. Marples RR, Kligman AM. Ecological effects of oral antibiotics on the microflora of human skin. Arch Dermatol 1971;103:148-53.
38. Webster GF, Leyden JJ, McGinley KJ, McArthur WP. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin. Antimicrob Agents Chemother 1982;21:770-2.
39. Leyden JJ. Open-label evaluation of topical antimicrobial and anti-acne preparations for effectiveness versus Propionibacterium acnes in vivo. Cutis 1992;49(6A):8-11.
40. Bladon PT, Burke BM, Cunliffe WJ, Forster RA, Holland KT, King K. Topical azelaic acid and the treatment of acne: a clinical and laboratory comparison with oral tetracycline. Br J Dermatol 1986;114:493-9.
41. Olsen TG. Therapy of acne. Med Clin North Am 1982;66:851-71.
42. Leyden JJ. Absorption of minocycline hydrochloride and tetracycline hydrochloride: effect of food, milk, and iron. J Am Acad Dermatol 1985; 12:308-12.
43. Leyden JJ, McGinley KJ, Cavalieri S, Webster GF, Mills OH, Kligman AM. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983;8:41-5.
44. Esterly NB, Koransky JS, Furey NL, Trevisan M. Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy. Arch Dermatol 1984;120:1308-13.
45. Eady EA, Cove JH, Blake J, Holland KT, Cunliffe WJ. Recalcitrant acne vulgaris: clinical, biochemical, and microbiological investigation of patients not responding to antibiotic treatment. Br J Dermatol 1988;118:415-23.
46. Eady EA, Jones CE, Tipper JL, Cove JH, Cunliffe WJ, Layton AM. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ 1993;306:555-6.
47. Verschoore M, Langner A, Wolska H, Jablonska S, Czernielewski J, Schaefer H. Efficacy and safety of CD 271 alcohol gels in the topical treatment of acne vulgaris. Br J Dermatol 1991;124:368-71.
48. Verschoore M, Langner A, Wolska M, Jablonska S, Czernielewski J. Vehicle controlled study of CD 271 lotion in the topical treatment of acne vulgaris. J Invest Dermatol 1993;100:221. abstract.
49. Kelly AP, Burns RE. Acute febrile ulcerative conglobate acne with polyarthralgia. Arch Dermatol 1971;104:182-7.
50. Goldschmidt H, Leyden JJ, Stein KH. Acne fulminans: investigation of acute febrile ulcerative acne. Arch Dermatol 1977;113:444-9.
51. Lane JM, Leyden JJ, Spiegel RJ. Acne arthralgia. J Bone Joint Surg Am 1976;58:673-5.
52. Nault P, Lassonde M, St-Antoine P. Acne fulminans with osteolytic lesions. Arch Dermatol 1985;121:662-4.
53. O'Leary PA, Kierland RR. Pyoderma faciale. Arch Dermatol Syphilol 1940;41:451-62.
54. Massa MC, Su WP. Pyoderma faciale: a clinical study of twenty-nine patients. J Am Acad Dermatol 1982;6:84-91.